HONG KONG SAR - Media OutReach Newswire - 3 February 2026 - Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become increasingly common in ...

A supplement advertised as a honey product used for energy support has been recalled because it contains a drug that users aren’t aware of. Ashfiat Alharamain Energy Support was distributed nationwide ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

Gestational diabetes mellitus (GDM) is characterized by glucose intolerance with onset or first recognition during pregnancy.

Adults with high esophageal hypervigilance and anxiety and worse esophageal function prior to achalasia treatment experienced ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

In the second chunky biotech raising so far this year, PYC Therapeutics is seeking $650 million via a placement and rights ...

Metabolic dysfunction-associated fatty liver disease (MAFLD), also known as non-alcoholic fatty liver disease (NAFLD), affects over 30% of the global adult population. Characterized by at least 5% ...

Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality worldwide. It occurs when thrombotic material—most often ...

Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...